News & Insights

global-cancer-technology-signs-agreement-with-barrow-neurological-institute-to-commercialize

Global Cancer Technology Signs Agreement with Barrow Neurological Institute to Commercialize

Global Cancer Technology Signs Agreement with Barrow Neurological Institute to…

a-novel-treatment-modality-for-covid-19

A Novel Treatment Modality for COVID-19

Global Cancer Technology is Developing a Light-emitting Nanoparticle Which May…

Medical Research Scientist Looking under the Microscope in the L

Licenses Autophagy Modulators from Neuropore Therapies

GLOBAL CANCER TECHNOLOGY LICENSES AUTOPHAGY MODULATORS FROM NEUROPORE THERAPIES FOR

Coronavirus Covid-19 background - 3d rendering

Global Cancer Technology Receives SEC Notice of Qualification for Reg A+ Tier II Registration

Company Plans to Raise $9 Million USD with Proceeds to Fund New COVID Treatment Using Nanoparticles, UV Light and…

global-cancer-technology-launches-regulation-cf

Global Cancer Technology launches Regulation CF

Global Cancer Technology launches Regulation CF equity crowdfunding campaign.

global-cancer-technology-appoints-dr-milan-makale-as-chief-technology-officer

Global Cancer Technology appoints Chief Technology Officer

Global Cancer Technology appoints UC San Diego Moores Cancer Center researcher, Dr…

remote-controlled-cancer-drug-delivery-platform

Remote-Controlled Cancer Drug Delivery Platform

New paradigm for killing deep-seated tumors without harming normal tissue.

31/31